[
  {
    "ts": null,
    "headline": "Abbott Laboratories stock underperforms Tuesday when compared to competitors",
    "summary": "Abbott Laboratories stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=d3386a40a5c6d264e4002594e352fafff212e923f03835ba6eb29d69a79e5552",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736872500,
      "headline": "Abbott Laboratories stock underperforms Tuesday when compared to competitors",
      "id": 132408847,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=d3386a40a5c6d264e4002594e352fafff212e923f03835ba6eb29d69a79e5552"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Standing Apart As A Rare Med-Tech Growth Story",
    "summary": "Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn more about BSX stock here.",
    "url": "https://finnhub.io/api/news?id=7f4fb2c6349c718a12b415851b47a1b37f45ac8fd25ba6c2c6aff762fee62e75",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736866345,
      "headline": "Boston Scientific Standing Apart As A Rare Med-Tech Growth Story",
      "id": 132395393,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2177217516/image_2177217516.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn more about BSX stock here.",
      "url": "https://finnhub.io/api/news?id=7f4fb2c6349c718a12b415851b47a1b37f45ac8fd25ba6c2c6aff762fee62e75"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Has Immense Cash Flow Potential",
    "summary": "AbbVie's strong financials and potential for cash flow make it a valuable investment, despite risks from patent expirations. Read more about ABBV stock here.",
    "url": "https://finnhub.io/api/news?id=537e8f7e60b15301ec90ca54b99308224f06d8a464e24f810982dc991f2eedf4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736831289,
      "headline": "AbbVie Has Immense Cash Flow Potential",
      "id": 132392573,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2175801616/image_2175801616.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "AbbVie's strong financials and potential for cash flow make it a valuable investment, despite risks from patent expirations. Read more about ABBV stock here.",
      "url": "https://finnhub.io/api/news?id=537e8f7e60b15301ec90ca54b99308224f06d8a464e24f810982dc991f2eedf4"
    }
  }
]